Previous close | 4.4000 |
Open | N/A |
Bid | 2.8000 |
Ask | 7.5000 |
Strike | 70.00 |
Expiry date | 2024-06-21 |
Day's range | 4.4000 - 4.4000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Investors need to pay close attention to ANI Pharmaceuticals (ANIP) stock based on the movements in the options market lately.
On June 4, 2024, Stephen Carey, Senior Vice President & Chief Financial Officer of ANI Pharmaceuticals Inc (NASDAQ:ANIP), sold 5,000 shares of the company.
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows: Date:June 5, 2024 Time:4:30 ET Webcast:Click Here To schedule a 1x1 meeting with the Company, please contact your Jefferies representative. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified bio